News

ICMR and CDSCO Release Comprehensive AMR Guidelines to Boost Pathogen Detection in India

The initiative, jointly developed by the Indian Council of Medical Research (ICMR) and the Central Drugs Standard Control Organization (CDSCO), aims to guide the validation of advanced diagnostic tools capable of detecting new pathogens and antimicrobial-resistant genes.

• By Pooja Chaturvedi Sah
• New Delhi
• Jan 17, 2025

News

India has taken a significant step in combating antimicrobial resistance (AMR) with the launch of its first comprehensive guidelines for testing technologies on Friday, 17 January.

The initiative, jointly developed by the Indian Council of Medical Research (ICMR) and the Central Drugs Standard Control Organization (CDSCO), aims to guide the validation of advanced diagnostic tools capable of detecting new pathogens and antimicrobial-resistant genes.

The 59-page document offers a detailed framework for innovators, outlining evidence requirements for developing and validating testing machines. These technologies are expected to leverage molecular diagnostics and artificial intelligence (AI) to enhance the detection and monitoring of AMR, which remains one of the most pressing global health challenges.

Key Highlights of the Guidelines

• Focus on Diagnostics: The guidelines detail how innovators can validate cutting-edge testing technologies to detect resistant strains. This includes technical protocols, evidence submission requirements, and performance metrics.

• Integration with AI: Advanced diagnostic tools using AI and molecular diagnostics are highlighted as key technologies to improve accuracy and efficiency in detecting resistant genes.

• Affordability and Scalability: Special emphasis is placed on making these tools cost-effective and scalable for widespread use in resource-limited settings, addressing India’s unique healthcare challenges.

• Pathogen Surveillance: By improving testing capabilities, the guidelines aim to strengthen India’s laboratory-based AMR surveillance system.

Dr. Rajiv Bahl, Director-General of ICMR, noted in his media interactions, “These guidelines will empower innovators to develop state-of-the-art testing technologies tailored to India’s healthcare needs. Early detection is crucial to curbing the spread of antimicrobial resistance.”

Why These Guidelines Are Critical

AMR arises primarily from the misuse and overuse of antibiotics, with India being one of the largest global consumers. Recent reports have highlighted the alarming rise of drug-resistant infections, which pose a serious threat to public health.

According to the World Health Organization (WHO), AMR could result in millions of deaths annually by 2050 without urgent interventions. India’s guidelines aim to address this crisis by encouraging innovation and fostering the development of affordable diagnostic tools.

The guidelines are also aligned with India’s National Action Plan on AMR, which emphasizes: 

1. Strengthening pathogen detection and surveillance. 

2. Promoting the rational use of antimicrobials in human and veterinary medicine. 

3. Reducing antibiotic use in agriculture. 

4. Raising awareness about AMR and infection control practices.

The launch of the AMR guidelines is part of India’s broader efforts to position itself as a leader in the global fight against antibiotic resistance. Unlike similar frameworks in other countries, India’s guidelines address local challenges by focusing on cost-effective solutions for underserved communities. The guidelines also address practical challenges in implementation.

India’s Broader AMR Strategy

While the guidelines focus on enabling innovation in diagnostics, they complement existing national initiatives:

• Development of New Antibiotics: Drugs like Nafithromycin are being developed to counter resistant strains.

• State-Level Innovation Hubs: Centers like the Bangalore Bioinnovation Centre are fostering R&D in AMR-focused diagnostics and therapeutics.

• Global Collaboration: India is actively contributing to international AMR efforts, including WHO-led initiatives.

India’s new AMR guidelines highlight the urgent need for coordinated global efforts to tackle the resistance crisis. By prioritizing early detection, a critical gap in managing AMR can be addressed. Experts believe this initiative could inspire similar frameworks worldwide, especially in developing nations facing similar healthcare challenges.